<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV)-immortalized lymphoblastoid cell lines derived from the peripheral blood of patients with <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> (AT) and EBV genome-positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) were tested for expression of EBV-related lytic antigens by means of irradiation </plain></SENT>
<SENT sid="1" pm="."><plain>We used 1 Gy in each experiment, according to the results of the P3HR-1 (derived from African <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell line </plain></SENT>
<SENT sid="2" pm="."><plain>Significantly higher expression of early antigens (EA) and <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) was demonstrated in lymphoblastoid cell lines derived from both patients with AT and those with EBV genome-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, as compared to those derived from healthy individuals </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggested that defective regulating mechanisms on B lymphocytes, responsible for <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e>, may underlie for the pathogenesis of development of <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e> both in patients with AT and EBV genome-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>